Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
J Clin Pathol. 2010 Feb;63(2):124-8. doi: 10.1136/jcp.2009.072256.
Angiomatoid fibrous histiocytoma (AFH) is a rare soft-tissue tumour of uncertain differentiation and low metastatic potential. Cytogenetics and/or molecular genetics have revealed that most have a rearrangement of the EWSR1 gene, whereas a FUS gene rearrangement is present in a minority of cases. Although some cases of AFH display striking pleomorphism and mitotic activity, there are no known clinical, morphological or genetic factors that predict metastasis. The authors present clinicopathological features of AFH, including cases showing a pleomorphic histological appearance, and results of fluorescence in situ hybridisation analysis of EWSR1 and FUS rearrangements.
Tumour samples from 10 patients were subjected to clinicopathological and immunohistochemical analysis and dual-colour fluorescence in situ hybridisation for EWSR1 and FUS with split-signal probes.
All cases showed clinical features (sites: extremities followed by trunk; age: adolescent to young adult), morphology (multinodular proliferation of spindle cells, lymphoid cuffs and pseudovascular spaces) and immunohistochemical results (more than half were positive for CD68, CD99, desmin and epithelial membrane antigen) typical of AFH. There were two local recurrences in each of two patients. Two patients developed distant metastases and died from the disease; tumours of these two patients showed focal proliferation of large pleomorphic cells with hyperchromatic nuclei and high proliferative activity (>10/10 high-power field and Ki-67 labelling index >10%). There were no clinical, histological or immunohistochemical differences between the nine cases with EWSR1 rearrangement and one case with FUS rearrangement.
Wide surgical excision and careful follow-up are necessary for patients with AFH in view of its risk of local recurrence and metastasis leading to a fatal outcome.
血管外皮细胞瘤样纤维组织细胞瘤(AFH)是一种分化不确定、转移潜能低的罕见软组织肿瘤。细胞遗传学和/或分子遗传学显示,大多数患者存在 EWSR1 基因重排,而少数病例存在 FUS 基因重排。尽管有些 AFH 病例表现出明显的多形性和有丝分裂活性,但目前尚无预测转移的已知临床、形态或遗传因素。作者介绍了 AFH 的临床病理特征,包括表现出多形性组织学外观的病例,以及 EWSR1 和 FUS 重排的荧光原位杂交分析结果。
对 10 例患者的肿瘤样本进行临床病理和免疫组织化学分析,并进行 EWSR1 和 FUS 双色荧光原位杂交,使用分裂信号探针。
所有病例均表现出临床特征(部位:四肢,其次是躯干;年龄:青少年至年轻成人)、形态学(梭形细胞多结节性增生、淋巴袖套和假血管空间)和免疫组织化学结果(超过一半的病例对 CD68、CD99、结蛋白和上皮膜抗原呈阳性),典型的 AFH。两名患者各有 2 例局部复发。两名患者发生远处转移并死于该疾病;这两名患者的肿瘤表现出大的多形性细胞局灶性增殖,核深染,增殖活性高(>10/10 高倍视野和 Ki-67 标记指数>10%)。在 9 例存在 EWSR1 重排的病例和 1 例存在 FUS 重排的病例之间,没有临床、组织学或免疫组织化学差异。
鉴于 AFH 存在局部复发和转移导致致命后果的风险,需要对患者进行广泛的手术切除和仔细的随访。